Back to results
US 2002/0173657 A1Published application
Method for the synthesis of quinoline derivatives
AssigneeSmithKline Beecham Corporation
InventorsMark Mellinger, Conrad Kowalski
Life of this patent
Estimating the term…
Abstract
This invention relates to novel intermediates and processes for preparing phamaceutically active quinoline compounds, including (−)-(S)-N-(α-ethylbenzyl)-3-hydroxy-2-phenylquinoline-4-carboxamide.
Claims10
A method for preparing a compound of formula (I):
- 36
- or a pharmaceutically acceptable salt form thereof, wherein:
- Ar is an optionally substituted phenyl group, or a naphthyl or C5-7 cycloalkdienyl group, or an optionally substituted single or fused ring heterocyclic group, having aromatic character, containing from 5 to 12 ring atoms and comprising up to four hetero-atoms in the or each ring selected from S, O, N;
- R is linear or branched C1-8 alkyl, C3-7 cycloalkyl, C4-7 cycloalkylalkyl an optionally substituted phenyl group or a phenyl C1-6 alkyl group, an optionally substituted five-membered heteroaromatic ring comprising up to four heteroatom selected from O and N, hydroxy C1-6 alkyl, di C1-6 alkylaminoalkyl, C1-6 acylaminoalkyl, C1-6 alkoxyalkyl, C1-6 alkylcarbonyl, carboxy, C1-6 alkoxycarbonyl, C1-6 alkoxycarbonyl C1-6 alkyl, aminocarbonyl, C1-6 alkylaminocarbonyl, di C1-6 alkylaminocarbonyl;
- or is a group —(CH2)p—when cyclized onto Ar, where p is 2 or 3;
- R1 and R2, which may be the same or different, are independently hydrogen or C1-6 linear or branched all, or together form a —(CH2)n—group in which n represents 3, 4, or 5;
- or R1 together with R forms a group —(CH2)q—, in which q is 2, 3,4 or 5;
- R3 and R4, which may be the same or different, are independently hydrogen, C1-6 linear or branched alkyl, C1-6 alkenyl, aryl, C1-6 alkoxy, hydroxy, halogen, nitro, cyano, carboxy, carboxamido, sulphonamido, trifluoromethyl, amino, mono- and di-C1-6 alkylamino, —O(CH2)rNT2, in which r is 2, 3, or 4 and T is C1-6 alkyl or it forms a heterocyclic group
- 37
- in which V and V1 are hydrogen and u is 0, 1 or 2;
- —O(CH2)s—OW2 in which s is 2, 3, or 4 and W is C1-6 alkyl;
- hydroxyalkyl mono- or di-alkylaminoalkyl, acylamino, alkylsulphonylamino, aminoacylamino, mono- or di-aklaminoacylamino;
- with up to four R3 substituents being present in the quinoline nucleus;
- or R4 is a group —(CH2)t—when cyclized onto R5 as aryl, in which t is 1, 2, or 3;
- and
- R5 is branched or linear C 1-6 alkyl, C3-7 cycloalkyl, C4-7 cycloalkylalkyl, optionally substituted aryl, wherein the optional substituent is one of hydroxy, halogen, C1-6 alkoxy or C1-6 alkyl, or an optionally substituted single or fused ring heterocyclic group, having aromatic character, containing from 5 to 12 ring atoms and comprising up to four hetero-atoms in the or each ring selected from S, O, N;
- comprising:
- 1) adding a compound of formula (III):
- 38
- to base in a suitable solvent, to form a first reaction mixture, adding to the first reaction mixture a compound of formula (II):
- 39
- to form a second reaction mixture, and heating the second reaction mixture to form a compound of formula (IV):
- 40
- 2) isolating the compound of formula (IV) and then reacting the compound of formula (IV), in a suitable solvent, with a base to form a third reaction mixture, cooling the third reaction mixture, and adding thionyl chloride to form a fourth reaction mixture;
- 3) adding a compound of formula (V):
- 41
- to the fourth reaction mixture to form a fifth reaction mixture;
- 4) heating the fifth reaction mixture;
- and
- 5) optionally Converting the compound of formula (1) to a pharmaceutically acceptable salt thereof, wherein Ar, R, R1, R2, R3, R4 and R5 as used in a compound of formula (II) through (V) are as define for a compound of formula (I).
27 more elements
A method for preparing (−)-(S)-N-(α-ethylbenzyl)-3-hydroxy-2-phenylquinoline-4-carboxamide comprising:
- 1) reacting 3-hydroxy-2-phenylquinoline-4-carboxylic acid, in a suitable solvent, with triethyl amine to form a first reaction mixture, cooling the first reaction mixture, and adding thionyl chloride to form a second ion mixture comprising 6,14,22,30Tetraphenyl-[1,5,9,13]tetraoxahexadecino[2,3-c:6,7-c′:10,11-c″:14,15-c′″]tetraquinoline-8,16,24,32-tetrone and Ethyl 3-acetoxy-2-phenylquinoline-4-carboxylate;
- 2) adding (S)-1-phenyl propylamine to the second reaction mixture to form a third reaction mixture comprising (−)-(S)-N-(α-ethylbenzyl)-3-hydroxy-2-phenylquinoline-4-carboxamide and (S)-2-Phenyl-4-[[(1-phenylpropyl)amino]carbonyl]-3-quinolinyl-3-hydroxy-2-phenyl-4-quinoline-carboxylate;
- 3) heating the third reaction mixture;
- and
- 4) optionally converting (−)-(S)-N-(α-ethylbenzyl)-3-hydroxy-2-phenylquinoline-4-carboxamide to a pharmaceutically acceptable salt.
2 more elements
A compound of formula (VII):
- 42
- wherein:
- Ar is an optionally substituted phenyl group, or a naphthyl or C5-7 cycloalkdienyl group, or an optionally substituted single or fused ring heterocyclic group, having aromatic character, containing from 5 to 12 ring atoms and comprising up to four hetero-atoms in the or each ring selected from S, O, N;
- and
- R3 is hydrogen, C1-6 linear or branched alkyl, C1-6 alkenyl, aryl, C1-6 alkoxy, hydroxy, halogen, nitro, cyano, carboxy, carboxamido, sulphonamido, trifluoromethyl, amino, mono- and di-C1-6 alkylamino, —O(CH2)r—NT2, in which r is 2, 3, or 4 and T is C1-6 alkyl or it forms a heterocyclic group
- 43
- in which V and V1 are hydrogen and u is 0, 1 or 2;
- —O(CH2)s-OW2 in which s is 2, 3, or 4 and W is C1-6 alkyl;
- hydroxyalkyl, mono- or di-alkylaminoalkyl, acylamino, alkylsulphonylamino, aminoacylamino, mono- or di-alkylaminoacylamino;
- with up to four R3 substituents being present in the quinoline nucleus;
- and
- R′4 is OH or OAc.
9 more elements
A compound which is (−)-(S)-N-(α-ethylbenzyl)-3-hydroxy-2-phenylquinoline-4-carboxamide, hydrochloride salt.
A method for preparing a compound of formula (Ia):
- 46
- wherein:
- Ar is an optionally substituted phenyl group, or a naphthyl or C5-7 cycloalkdienyl group, or an optionally substituted single or fused ring heterocyclic group, having aromatic character, containing from 5 to 12 ring atoms and comprising up to four hetero-atoms in the or each ring selected from S, O, N;
- R is linear or branched C1-8 alkyl, C3-7 cycloalkyl, C4-7 cycloalkylalkyl, an optionally substituted phenyl group or a phenyl C1-6 alkyl group, an optionally substituted five-membered heteroaromatic ring comprising up to four heteroatom selected from O and N, hydroxy C1-6 alkyl, di C1-6 alkylaminoalkyl, C1-6 acylaminoalkyl, C1-6 alkylcarbonyl, carboxy, C1-6 alkoxycarbonyl, C1-6 alkoxycarbonyl C1-6 alkyl, aminocarbonyl, C1-6 alkylaminocarbonyl, di C1-6 alkylaminocarbonyl;
- or is a group —(CH2)p—when cyclized onto Ar, where p is 2 or 3;
- R2 is hydrogen or C1-6 linear or branched alkyl;
- and
- R3 and R4, which may be the same or different, are independently hydrogen, C1-6 linear or branched alkyl, C1-6 alkenyl, aryl, C1-6 alkoxy, hydroxy, halogen, nitro, cyano, carboxy, carboxamido, sulphonamido, trifluoromethyl, amino, mono- and di-C1-6 alkylamino, —O(CH2)rNT2, in which r is 2, 3, or 4 and T is C1-6 alkyl or it forms a heterocyclic group
- 47
- in which V and V1 are hydrogen and u is 0, 1 or 2;
- —O(CH2)s-OW2 in which s is 2, 3, or 4 and W is C1-4 alkyl;
- hydroxyalkyl, mono- or di-alkylaminoalkyl acylamino, alkylsulphonylamino, aminoacylamino, mono- or di-alkylaminoacylamino;
- with up to four R3 substituents being present in the quinoline nucleus;
- comprising:
- 1) adding a compound of formula (III):
- 48
- to base in a suitable solvent, to form a first reaction mixture, adding to the first reaction mixture a compound of formula (IIa):
- 49
- to form a second reaction mixture, and heating the second reaction mixture to form a compound of formula (IVa):
- 50
- 2) isolating the compound of formula (IVa) and then reacting the compound of formula (IVa), in a suitable solvent, with a base to form a third reaction mixture, cooling the third reaction mixture, and adding a carbonyl-activating agent to form a fourth reaction mixture;
- 3) adding a compound of formula (Va):
- 51
- to the fourth reaction mixture to form a fifth reaction mixture;
- 4) beating the fifth reaction mixture;
- and
- 5) optionally converting the compound of formula (I) to a pharmaceutically acceptable salt thereof, wherein Ar, R, R1, R2, R3, R4, and R5 as used in a compound of formulae (IIa), and (IVa) through (VIa) are as defined for a compound of formula (Ia).
24 more elements
Dependencies are inferred from the claim text.